Literature DB >> 9053558

Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts.

G Dacremont1, G Vincent.   

Abstract

The direct transesterification method of Lepage and Roy is described as used in our laboratory for the analysis of plasmalogens and polyunsaturated fatty acids in erythrocytes and cultured fibroblasts by gas chromatography. An overview is given of the plasmalogen ratios and docosahexaenoic acid concentrations from controls and patients with different peroxisomal disorders investigated in our laboratory.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 9053558     DOI： 10.1007/bf00711431

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  13 in total

1.  Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder.

Authors:  R J Wanders; H Schumacher; J Heikoop; R B Schutgens; J M Tager
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Treatment with docosahexaenoic acid favorably modifies the fatty acid composition of erythrocytes in peroxisomal patients.

Authors:  M Martinez
Journal:  Prog Clin Biol Res       Date:  1992

3.  Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder.

Authors:  R J Wanders; C Dekker; V A Hovarth; R B Schutgens; J M Tager; P Van Laer; D Lecoutere
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Polyunsaturated fatty acids in the developing human brain, red cells and plasma: influence of nutrition and peroxisomal disease.

Authors:  M Martinez
Journal:  World Rev Nutr Diet       Date:  1994       Impact factor: 0.575

Review 5.  Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.

Authors:  M Martinez
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Simple diagnosis of the Zellweger syndrome by gas-liquid chromatography of dimethylacetals.

Authors:  I Björkhem; L Sisfontes; B Boström; B F Kase; R Blomstrand
Journal:  J Lipid Res       Date:  1986-07       Impact factor: 5.922

Review 7.  Postnatal diagnosis of peroxisomal disorders: a biochemical approach.

Authors:  R J Wanders; R B Schutgens; P G Barth; J M Tager; H van den Bosch
Journal:  Biochimie       Date:  1993       Impact factor: 4.079

8.  Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.

Authors:  M Martinez; I Mougan; M Roig; A Ballabriga
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

9.  Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome.

Authors:  M Martinez
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

10.  Direct transesterification of all classes of lipids in a one-step reaction.

Authors:  G Lepage; C C Roy
Journal:  J Lipid Res       Date:  1986-01       Impact factor: 5.922
View more
  29 in total

1.  Analysis of plasmenylethanolamines using electrospray tandem mass spectrometry and its application in screening for peroxisomal disorders.

Authors:  P Vreken; F Valianpour; H Overmars; P G Barth; J J Selhorst; A H van Gennip; R J Wanders
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 2.  Antenatal manifestations of inborn errors of metabolism: biological diagnosis.

Authors:  Christine Vianey-Saban; Cécile Acquaviva; David Cheillan; Sophie Collardeau-Frachon; Laurent Guibaud; Cécile Pagan; Magali Pettazzoni; Monique Piraud; Antonin Lamazière; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.982

3.  A novel mutation in the PEX12 gene causing a peroxisomal biogenesis disorder.

Authors:  Jana Konkoľová; Robert Petrovič; Ján Chandoga; Edita Halasová; Petra Jungová; Daniel Böhmer
Journal:  Mol Biol Rep       Date:  2015-06-21       Impact factor: 2.316

4.  Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia.

Authors:  Mathilde Renaud; Claire Guissart; Martial Mallaret; Sacha Ferdinandusse; David Cheillan; Nathalie Drouot; Jean Muller; Mireille Claustres; Christine Tranchant; Mathieu Anheim; Michel Koenig
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

5.  Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.

Authors:  D Hahnel; T Huber; V Kurze; K Beyer; B Engelmann
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

6.  Abnormality in catalase import into peroxisomes leads to severe neurological disorder.

Authors:  F G Sheikh; K Pahan; M Khan; E Barbosa; I Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Plasma and erythrocyte fatty acid concentrations in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  A M Lund; M A Dixon; P Vreken; J V Leonard; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.

Authors:  Mushfiquddin Khan; Jaspreet Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-06-07       Impact factor: 5.372

9.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

10.  Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.

Authors:  Femke C C Klouwer; Sacha Ferdinandusse; Henk van Lenthe; Wim Kulik; Ronald J A Wanders; Bwee Tien Poll-The; Hans R Waterham; Frédéric M Vaz
Journal:  J Inherit Metab Dis       Date:  2017-07-04       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.